Results 181 to 190 of about 1,093,324 (351)
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo+7 more
wiley +1 more source
Transcatheter vs. surgical aortic valve replacement in bicuspid aortic valve stenosis. [PDF]
Kassab J+7 more
europepmc +1 more source
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk+12 more
wiley +1 more source
CONGENITAL BICUSPID AORTIC VALVES: A CLINICAL AND HAeMODYNAMIC STUDY [PDF]
Lamberto G. Bentivoglio+3 more
openalex +1 more source
Case report of isolated aortic valve AL-amyloidosis following aortic valve replacement. [PDF]
Choudhury R+3 more
europepmc +1 more source
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli+17 more
wiley +1 more source
Transcatheter aortic valve replacement or surgical aortic valve replacement: Establishing a middle ground. [PDF]
Bhogal S, Bhandari T, Batta A, Mohan B.
europepmc +1 more source
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies+23 more
wiley +1 more source